Parenteral Packaging Challenges? Our Glass Expertise Can Help!
Scientists in the pharmaceutical industry battle a lot of unique drug challenges with respect to their parenteral primary packaging, be it pH shifts, drug instability, ineffective lyophilization or light sensitivity. At SCHOTT Tubing in India, we understand your challenges: Our glass, FIOLAX ®, needed for pharmaceutical containers is designed to address these specific needs since 1911 and locally since 1998. Read more to understand our solutions to address your primary packaging challenges.
pH stability
Drug formulations, including water for injection, can be stored safely thanks to the excellent barrier properties of glass. FIOLAX® is a borosilicate glass tubing with low alkali content that reduces alkali borate appearance. This offers impressive hydrolytic and chemical glass resistance, minimizing the risk of drug container interactions.
The tubing product line FIOLAX® clear CHR is beneficial for highly demanding formulations. These formulations are sensitive to extractables such as sodium in pH-sensitive / unbuffered formulations. Here, hydrolytic resistance of the inner glass surface along with glass grains is monitored.
Get your free white paper now
The tubing product line FIOLAX® clear CHR is beneficial for highly demanding formulations. These formulations are sensitive to extractables such as sodium in pH-sensitive / unbuffered formulations. Here, hydrolytic resistance of the inner glass surface along with glass grains is monitored.
Drug stability
Biotech drugs have become increasingly important. These drugs are often sensitive to factors like oxygen, water vapor, pH changes, glass composition making the choice of glass packaging critical. Inadequate glass quality can lead to interactions that may degrade or compromise the drug's effectiveness.
That’s why SCHOTT’s FIOLAX® glass tubing portfolio offers superior barrier properties, high temperature and thermal shock resistance with low alkali content since 1911. FIOLAX® clear CHR tubing product line ensures controlled low sodium release, improved Extractables & Leachables profile and monitored hydrolytic resistance.
Get your free white paper now
That’s why SCHOTT’s FIOLAX® glass tubing portfolio offers superior barrier properties, high temperature and thermal shock resistance with low alkali content since 1911. FIOLAX® clear CHR tubing product line ensures controlled low sodium release, improved Extractables & Leachables profile and monitored hydrolytic resistance.
Drug lyophilization
Lyophilization, or freeze-drying, preserves injectable drugs by removing water. This is a demanding procedure as the parenteral container is frozen from inside and at the same time heated from the bottom. A container made of FIOLAX® tubing (CTE of 4.9) can bear a temperature difference of almost 200°C and therefore has optimal temperature shock resistance.
Also, did you know that internal pressure during lyophilization challenges the strength of the glass, and any surface defects can further weaken it? Our product line FIOLAX® clear with Optimized Strength (OS) tubing is developed with special attention to avoid surface defects.
Get your free white paper now
Also, did you know that internal pressure during lyophilization challenges the strength of the glass, and any surface defects can further weaken it? Our product line FIOLAX® clear with Optimized Strength (OS) tubing is developed with special attention to avoid surface defects.
Light sensitivity
Light-sensitive drugs require special packaging to prevent photolytic degradation. Glass with Iron (Fe) and Titanium (Ti) give a brownish color effectively absorbing UV light (200-400 nm), ensuring drug protection. FIOLAX® amber tubing helps to secure the long-term stability of light-sensitive drugs. The stable composition of this Type I glass ensures consistent amber color and light protection, achieved by adding iron and titanium oxide.
Light transmittance can also be controlled by the container's wall thickness and the annealing temperature. Thicker walls and higher temperatures result in darker glass and less light penetration.
Get your free white paper now
Light transmittance can also be controlled by the container's wall thickness and the annealing temperature. Thicker walls and higher temperatures result in darker glass and less light penetration.
Trusted excellence in pharmaceutical tubing
With over 140 years of experience, SCHOTT is a globally trusted brand. Established in 1998, SCHOTT Glass India Pvt. Ltd. operates a major pharmaceutical tubing production site in Jambusar, Gujarat and a sales office in Mumbai. The Indian plant is the second largest in SCHOTT's global tubing production network, serving both the domestic market and exporting to Asia and the Middle East.
More about FIOLAX® Type I Tubing
25 yrs of experience in India
SCHOTT's 2nd largest tubing site
ISO 9001, 15378, 14001, 45001 certified
1/6
2/6
3/6
4/6
5/6
6/6
Sundeep Prabhu
Sr. VP Sales and Marketing - Pharmaceutical Tubing